A previously healthy New Jersey man has been identified by an allergist at the University of Virginia (UVA) and his coauthors ...

Since highly pathogenic avian influenza virus (HPAIV) spread to the island of South Georgia in the sub-Antarctic in 2023, its ...

Developed by British drugmaker GSK, RTS,S/AS01E in 2021 became the first malaria vaccine to be recommended by the World ...

Earlier this month, a group of Canadian researchers published early influenza data for the 2025-26 season, issuing a warning: ...

Hundreds of malaria patients enrolled in a phase 3 clinical trial in Gabon, West Africa, were successfully treated with a one ...

At three months, relative to controls, greater improvements in intervention recipients were also seen for depression and ...

Infection with the mpox virus (MPXV) confers strong immunity against future infection for up to two years, compared with ...

A large study of US adults 65 and older enrolled in Medicare finds that the risk of Guillain-Barre syndrome (GBS)—a rare ...

Over the weekend Utah and South Carolina, the current hot spots of measles activity in the United States, saw case counts ...

A phase 1 randomized controlled trial of an experimental intranasal vaccine against multiple H5N1 avian flu strains generated ...

The onset of several conditions, including allergic rhinitis, viral infections, and ear infections, was also delayed after ...

The long-acting monoclonal antibody nirsevimab (Beyfortus) protects children younger than 2 years from respiratory syncytial ...